NCT04489862 αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT04450043 The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance Status ACTIVE_NOT_RECRUITING Phase NA
NCT04431024 Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome Status RECRUITING Phase N/A
NCT04429204 Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma Status WITHDRAWN Phase NA
NCT04375267 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours Status COMPLETED Phase PHASE1
NCT04334759 DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma Status COMPLETED Phase PHASE3
NCT04301011 Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors Status TERMINATED Phase PHASE1
NCT04300244 Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04272034 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04242199 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04234113 Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04214015 A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma Status WITHDRAWN Phase N/A
NCT04153565 A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17) Status COMPLETED Phase PHASE1
NCT04056026 A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma Status COMPLETED Phase EARLY_PHASE1
NCT04040231 Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma Status COMPLETED Phase PHASE1